Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 121422
Published online Aug 15, 2026. doi: 10.4239/wjd.121422
Published online Aug 15, 2026. doi: 10.4239/wjd.121422
Table 1 Baseline characteristics of patients with non-type 2 diabetes mellitus and type 2 diabetes mellitus, n (%)/median (interquartile range)
| Variables | Total | Non-T2DM patients | T2DM patients | P value |
| n | 4589 | 3220 | 1369 | |
| Baseline characteristic | ||||
| Age (years) | 55.00 (45.00, 63.00) | 53.00 (41.00, 60.00) | 60.00 (53.00, 67.00) | < 0.001 |
| BMI (kg/m2) | 23.73 (21.48, 25.95) | 23.62 (21.40, 25.84) | 24.02 (21.88, 26.22) | < 0.001 |
| Male sex | 2665 (58.07) | 1756 (54.53) | 909 (66.40) | < 0.001 |
| Smoke | 946 (20.61) | 650 (20.19) | 296 (21.62) | 0.271 |
| Alcohol | 709 (15.45) | 543 (16.86) | 166 (12.13) | < 0.001 |
| Hypertension | 2377 (51.80) | 1248 (38.76) | 1129 (82.47) | < 0.001 |
| Dyslipidemia | 2598 (56.61) | 1646 (51.12) | 952 (69.54) | < 0.001 |
| Laboratory findings | ||||
| HDL-cholesterol (mmol/L) | 1.09 (0.90, 1.34) | 1.14 (0.95, 1.39) | 0.95 (0.78, 1.21) | < 0.001 |
| LDL-cholesterol (mmol/L) | 2.67 (2.04, 3.37) | 2.78 (2.19, 3.49) | 2.35 (1.74, 3.06) | < 0.001 |
| Total cholesterol (mmol/L) | 4.40 (3.68, 5.36) | 4.53 (3.84, 5.45) | 4.05 (3.31, 5.12) | < 0.001 |
| Triglyceride (mmol/L) | 1.52 (1.03, 2.35) | 1.44 (1.00, 2.21) | 1.70 (1.13, 2.65) | < 0.001 |
| Fast glucose (mmol/L) | 5.44 (4.89, 6.52) | 5.18 (4.79, 5.69) | 8.01 (6.10, 11.20) | < 0.001 |
| CT findings | ||||
| BMD (mg/cm3) | 173.37 (149.18, 196.47) | 176.72 (151.09, 200.71) | 167.90 (144.78, 187.61) | < 0.001 |
| EAT volume (cm3) | 139.89 (95.68, 196.14) | 132.59 (91.86, 184.31) | 160.57 (111.34, 215.94) | < 0.001 |
| EAT density (HU) | -77.06 (-82.28, -72.03) | -77.79 (-82.55, -72.99) | -75.07 (-81.41, -69.36) | < 0.001 |
| CACS | 0.00 (0.00, 60.53) | 0.00 (0.00, 5.02) | 61.20 (0.00, 330.42) | < 0.001 |
| CAC category | < 0.001 | |||
| 0 | 2671 (58.20) | 2286 (70.99) | 385 (28.12) | |
| 1-100 | 948 (20.66) | 566 (17.58) | 382 (27.90) | |
| 101-300 | 448 (9.76) | 203 (6.30) | 245 (17.90) | |
| > 300 | 522 (11.38) | 165 (5.12) | 357 (26.08) |
Table 2 Baseline characteristics of patients with type 2 diabetes mellitus stratified by duration, n (%)/median (interquartile range)
| Variables | Short-duration | Intermediate-duration | Long-duration | P value |
| n | 355 | 311 | 703 | |
| Baseline characteristic | ||||
| Age (years) | 57.00 (49.00, 64.00) | 59.00 (52.00, 67.00) | 61.00 (55.00, 69.00) | < 0.001 |
| BMI (kg/m2) | 24.09 (21.60, 26.26) | 24.37 (22.03, 26.66) | 23.81 (21.88, 26.10) | 0.190 |
| Male sex | 223 (62.82) | 214 (68.81) | 472 (67.14) | 0.220 |
| Smoke | 84 (23.66) | 72 (23.15) | 140 (19.91) | 0.285 |
| Alcohol | 38 (10.70) | 41 (13.18) | 87 (12.38) | 0.594 |
| Hypertension | 273 (76.90) | 242 (77.81) | 614 (87.34) | < 0.001 |
| Dyslipidemia | 256 (72.11) | 206 (66.24) | 490 (69.70) | 0.257 |
| Laboratory findings | ||||
| HDL-cholesterol (mmol/L) | 0.98 (0.79, 1.28) | 0.96 (0.78, 1.21) | 0.94 (0.78, 1.16) | 0.084 |
| LDL-cholesterol (mmol/L) | 2.53 (1.86, 3.43) | 2.47 (1.79, 3.00) | 2.23 (1.68, 2.97) | < 0.001 |
| Total cholesterol (mmol/L) | 4.40 (3.45, 5.70) | 4.11 (3.43, 5.10) | 3.91 (3.20, 4.86) | < 0.001 |
| Triglyceride (mmol/L) | 1.89 (1.21, 3.21) | 1.66 (1.14, 2.40) | 1.63 (1.08, 2.46) | 0.001 |
| HbA1c (%) | 7.00 (6.30, 7.10) | 7.00 (6.30, 7.00) | 6.90 (6.35, 7.10) | 0.008 |
| Fast glucose (mmol/L) | 7.49 (5.97, 10.52) | 7.65 (6.04, 10.56) | 8.51 (6.25, 11.72) | 0.002 |
| CT findings | ||||
| BMD (mg/cm3) | 171.70 (148.95, 191.93) | 168.83 (145.90, 185.79) | 166.44 (141.91, 186.12) | 0.013 |
| EAT volume (cm3) | 157.95 (107.31, 214.17) | 167.29 (114.66, 220.84) | 160.16 (110.63, 214.58) | 0.491 |
| EAT density (HU) | -76.84 (-83.17, -70.48) | -74.91 (-81.98, -69.52) | -74.36 (-80.03, -69.10) | < 0.001 |
| CACS | 12.87 (0.00, 145.79) | 34.09 (0.00, 260.27) | 116.96 (7.63, 496.13) | < 0.001 |
| CAC category | < 0.001 | |||
| 0 | 139 (39.15) | 99 (31.83) | 147 (20.91) | |
| 1-100 | 111 (31.27) | 89 (28.62) | 182 (25.89) | |
| 101-300 | 49 (13.80) | 52 (16.72) | 144 (20.48) | |
| > 300 | 56 (15.77) | 71 (22.83) | 230 (32.72) |
Table 3 Comparison between non-type 2 diabetes mellitus patients and type 2 diabetes mellitus patients with different durations after matching, n (%)/median (interquartile range)
| Variables | Non-T2DM vs short-duration T2DM | P value | Non-T2DM vs intermediate-duration T2DM | P value | Non-T2DM vs long-duration T2DM | P value | |||
| Non-T2DM | Short-duration T2DM | Non-T2DM | Intermediate-duration T2DM | Non-T2DM | Long-duration T2DM | ||||
| n | 355 | 355 | 308 | 308 | 664 | 664 | |||
| Age (years) | 57.00 (50.00, 64.00) | 57.00 (49.00, 64.00) | 0.937 | 59.00 (51.75, 66.00) | 59.00 (52.00, 67.00) | 0.746 | 59.00 (54.00, 67.00) | 60.00 (54.00, 68.00) | 0.133 |
| BMI (kg/m2) | 24.02 (21.64, 26.13) | 24.09 (21.60, 26.26) | 0.874 | 24.22 (22.35, 26.45) | 24.32 (22.03, 26.68) | 0.878 | 24.12 (22.20, 26.23) | 23.88 (21.88, 26.18) | 0.218 |
| Male sex | 203 (57.18) | 223 (62.82) | 0.125 | 221 (71.75) | 211 (68.51) | 0.379 | 457 (68.83) | 447 (67.32) | 0.556 |
| Smoke | 75 (21.13) | 84 (23.66) | 0.418 | 84 (27.27) | 71 (23.05) | 0.227 | 137 (20.63) | 133 (20.03) | 0.785 |
| Alcohol | 37 (10.42) | 38 (10.70) | 0.903 | 52 (16.88) | 41 (13.31) | 0.216 | 82 (12.35) | 86 (12.95) | 0.741 |
| Hypertension | 274 (77.18) | 273 (76.90) | 0.929 | 239 (77.60) | 239 (77.60) | 1.000 | 574 (86.45) | 575 (86.60) | 0.936 |
| Dyslipidemia | 263 (74.08) | 256 (72.11) | 0.554 | 213 (69.16) | 203 (65.91) | 0.390 | 458 (68.98) | 452 (68.07) | 0.723 |
| Fast glucose (mmol/L) | 5.25 (4.85, 5.78) | 7.49 (5.97, 10.52) | < 0.001 | 5.24 (4.86, 5.79) | 7.66 (6.02, 10.56) | < 0.001 | 5.24 (4.84, 5.79) | 8.57 (6.26, 11.71) | < 0.001 |
| CACS | 0.00 (0.00, 27.55) | 12.87 (0.00, 145.79) | < 0.001 | 0.00 (0.00, 34.71) | 34.00 (0.00, 257.59) | < 0.001 | 0.00 (0.00, 66.40) | 113.28 (7.31, 470.36) | < 0.001 |
| CAC category | < 0.001 | < 0.001 | < 0.001 | ||||||
| 0 | 212 (59.72) | 139 (39.15) | 180 (58.44) | 98 (31.82) | 357 (53.77) | 143 (21.54) | |||
| 1-100 | 87 (24.51) | 111 (31.27) | 72 (23.38) | 89 (28.90) | 164 (24.70) | 174 (26.20) | |||
| 101-300 | 32 (9.01) | 49 (13.80) | 33 (10.71) | 51 (16.56) | 67 (10.09) | 139 (20.93) | |||
| > 300 | 24 (6.76) | 56 (15.77) | 23 (7.47) | 70 (22.73) | 76 (11.45) | 208 (31.33) | |||
| BMD (mg/cm3) | 167.53 (145.37, 193.04) | 171.70 (148.95, 191.93) | 0.430 | 169.01 (145.01, 189.85) | 169.32 (146.29, 185.90) | 0.874 | 163.40 (141.82, 185.09) | 166.87 (142.84, 186.62) | 0.722 |
| EAT volume (cm3) | 149.17 (106.21, 202.46) | 157.95 (107.31, 214.17) | 0.338 | 166.60 (126.41, 218.08) | 166.26 (114.52, 219.02) | 0.495 | 162.74 (120.21, 213.48) | 158.94 (109.21, 213.74) | 0.144 |
| EAT density (HU) | -78.71 (-83.49, -74.02) | -76.84 (-83.17, | 0.006 | -80.56 (-85.52, -75.47) | -74.88 (-81.88, -69.48) | < 0.001 | -79.95 (-84.58, -75.21) | -74.17 (-80.02, | < 0.001 |
Table 4 Comparison between type 2 diabetes mellitus patients with different durations after matching, n (%)/median (interquartile range)
| Variables | Short-duration vs intermediate-duration | P value | Short-duration vs long-duration | P value | Intermediate-duration vs long-duration | P value | |||
| Short-duration | Intermediate-duration | Short-duration | Long-duration | Intermediate-duration | Long-duration | ||||
| n | 267 | 267 | 310 | 310 | 305 | 305 | |||
| Age (years) | 58.00 (51.00, 66.00) | 58.00 (52.00, 65.00) | 0.878 | 57.00 (50.00, 65.00) | 59.00 (51.25, 66.00) | 0.114 | 59.00 (52.00, 67.00) | 60.00 (54.00, 68.00) | 0.082 |
| BMI (kg/m2) | 24.04 (21.51, 26.09) | 24.37 (22.01, 26.69) | 0.148 | 24.14 (21.54, 25.96) | 23.88 (21.89, 26.13) | 0.785 | 24.38 (22.03, 26.67) | 23.74 (21.89, 26.12) | 0.147 |
| Male sex | 181 (67.79) | 178 (66.67) | 0.782 | 196 (63.23) | 202 (65.16) | 0.615 | 209 (68.52) | 201 (65.90) | 0.490 |
| Smoke | 61 (22.85) | 63 (23.60) | 0.838 | 67 (21.61) | 74 (23.87) | 0.502 | 69 (22.62) | 66 (21.64) | 0.770 |
| Alcohol | 27 (10.11) | 32 (11.99) | 0.490 | 35 (11.29) | 42 (13.55) | 0.394 | 39 (12.79) | 37 (12.13) | 0.806 |
| Hypertension | 208 (77.90) | 206 (77.15) | 0.836 | 246 (79.35) | 251 (80.97) | 0.615 | 241 (79.02) | 250 (81.97) | 0.358 |
| Dyslipidemia | 188 (70.41) | 173 (64.79) | 0.165 | 220 (70.97) | 222 (71.61) | 0.859 | 200 (65.57) | 209 (68.52) | 0.438 |
| Fast glucose (mmol/L) | 7.49 (6.04, 10.59) | 7.66 (6.04, 10.61) | 0.621 | 7.43 (5.97, 10.43) | 8.61 (6.52, 11.93) | < 0.001 | 7.65 (6.04, 10.65) | 8.72 (6.52, 11.22) | 0.015 |
| HbA1c (%) | 7.00 (6.30, 7.10) | 7.00 (6.35, 7.00) | 0.289 | 7.00 (6.30, 7.10) | 7.00 (6.40, 7.27) | 0.775 | 7.00 (6.30, 7.00) | 6.90 (6.40, 7.10) | 0.574 |
| CACS | 21.14 (0.00, 161.95) | 32.04 (0.00, 213.55) | 0.426 | 18.96 (0.00, 164.64) | 79.28 (0.00, 326.17) | < 0.001 | 35.05 (0.00, 265.64) | 121.49 (7.85, 492.69) | < 0.001 |
| CAC category | 0.697 | 0.001 | 0.003 | ||||||
| 0 | 96 (35.96) | 88 (32.96) | 112 (36.13) | 84 (27.10) | 94 (30.82) | 61 (20.00) | |||
| 1-100 | 85 (31.84) | 80 (29.96) | 99 (31.94) | 79 (25.48) | 89 (29.18) | 79 (25.90) | |||
| 101-300 | 39 (14.61) | 46 (17.23) | 46 (14.84) | 62 (20.00) | 52 (17.05) | 67 (21.97) | |||
| > 300 | 47 (17.60) | 53 (19.85) | 53 (17.10) | 85 (27.42) | 70 (22.95) | 98 (32.13) | |||
| BMD (mg/cm3) | 166.10 (147.47, 190.49) | 170.11 (147.51, 187.26) | 0.900 | 171.64 (149.81, 191.01) | 170.02 (144.57, 188.12) | 0.222 | 168.83 (145.61, 185.70) | 167.88 (141.91, 186.09) | 0.445 |
| EAT volume (cm3) | 155.47 (105.92, 220.46) | 159.70 (113.23, 210.34) | 0.969 | 156.71 (107.58, 215.17) | 151.50 (104.02, 210.74) | 0.508 | 168.09 (115.08, 221.18) | 157.13 (110.40, 212.37) | 0.276 |
| EAT density (HU) | -75.93 (-82.31, -69.26) | -75.20 (-82.29, | 0.833 | -76.30 (-83.13, -69.80) | -74.38 (-79.66, -69.31) | 0.004 | -74.95 (-81.93, | -74.64 (-79.70, -69.28) | 0.204 |
Table 5 Multivariate linear regression analysis of type 2 diabetes mellitus with bone mineral density, epicardial adipose tissue volume, and epicardial adipose tissue density
| Model | BMD | EAT volume | EAT density | |||
| β (95%CI) | P value | β (95%CI) | P value | β (95%CI) | P value | |
| Model 1 | -9.579 (-11.617 to -7.542) | < 0.001 | 24.122 (19.546-28.697) | < 0.001 | 2.255 (1.711-2.799) | < 0.001 |
| Model 2 | 1.411 (-0.411 to 3.233) | 0.129 | 4.304 (-0.070 to 8.679) | 0.054 | 3.611 (3.055-4.167) | < 0.001 |
| Model 3 | 0.506 (-1.477 to 2.489) | 0.617 | -3.363 (-8.056 to 1.331) | 0.16 | 4.131 (3.528-4.733) | < 0.001 |
Table 6 Multivariate logistic regression analysis of type 2 diabetes mellitus with severe coronary artery calcification
| Variables | SCAC | |
| OR (95%CI) | P value | |
| Model 1 | 6.532 (5.360-7.960) | < 0.001 |
| Model 2 | 4.294 (3.487-5.288) | < 0.001 |
| Model 3 | 3.656 (2.903-4.604) | < 0.001 |
Table 7 Threshold effect analysis of the relationship between bone mineral density and epicardial adipose tissue density
| Model | Threshold | β (95%CI) | P value |
| Model 1: Standard linear regression | - | -0.06 (-0.07 to -0.06) | < 0.001 |
| Model 2: Piecewise linear regression | - | - | - |
| Threshold | 174.91 | - | - |
| < 174.91 | - | -0.12 (-0.13 to -0.10) | < 0.001 |
| ≥ 174.91 | - | 0.02 (-0.00 to 0.04) | 0.060 |
| Likelihood ratio test P | - | - | < 0.001 |
- Citation: Liu YK, Wu FY, Jiang CP, Xia YX, Li Y, Zeng WW, Zhang SY, Fan DN, Zhang MX, Liu TC, Wu XP, Dong Y, Chen W, Zhao YH, Li T, Li Z, Xu XY. Artificial intelligence-based chest computed tomography assessment of bone, vascular, and epicardial adipose changes in type 2 diabetes. World J Diabetes 2026; 17(8): 121422
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/121422.htm
- DOI: https://dx.doi.org/10.4239/wjd.121422